Second-trimester abortion for fetal anomalies or fetal death: Labor induction compared with dilation and evacuation

Obstetrics and Gynecology

Volumn 117, Issue 4, 2011, Pages 788-792

  Bryant, Amy G ^a,b   Grimes, David A ^a   Garrett, Joanne M ^a   Stuart, Gretchen S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b 3031 Old Clinic Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DILATION AND EVACUATION; FEMALE; FETUS DEATH; FETUS MALFORMATION; HUMAN; INTERMETHOD COMPARISON; LABOR INDUCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECOND TRIMESTER ABORTION; TREATMENT INDICATION;

ABORTION, INDUCED; ADULT; COHORT STUDIES; CONFIDENCE INTERVALS; CONGENITAL ABNORMALITIES; DILATATION AND CURETTAGE; FEMALE; FETAL DEATH; FOLLOW-UP STUDIES; HUMANS; LABOR, INDUCED; MATERNAL WELFARE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAFETY MANAGEMENT; STATISTICS, NONPARAMETRIC; VACUUM CURETTAGE; YOUNG ADULT;

EID: 79953180575     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31820c3d26     Document Type: Article

References (27)

1. Kelly T, Suddes J, Howel D, Hewison J, Robson S. Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial. BJOG 2010; 117:1512-20.
2. Neilson JP, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). The Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD002253. DOI: 10.1002/14651858.CD002253.pub3.
3. le Roux PA, Pahal GS, Hoffman L, Nooh R, El-Refaey H, Rodeck CH. Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost. Eur J Obstet Gynecol Reprod Biol 2001;95:52-4. (Pubitemid 32208670)
4. Rauch ER, Smulian JC, DePrince K, Ananth CV, Marcella SW; New Jersey Fetal Abnormalities Registry. Pregnancy interruption after second trimester diagnosis of fetal structural anomalies: the New Jersey Fetal Abnormalities Registry. Am J Obstet Gynecol 2005;193:1492-7. (Pubitemid 41395122)
5. Shulman LP, Ling FW, Meyers CM, Shanklin DR, Simpson JL, Elias S. Dilation and evacuation for second-trimester genetic pregnancy termination. Obstet Gynecol 1990;75: 1037-40. (Pubitemid 20176780)
6. Autry AM, Hayes EC, Jacobson GF, Kirby RS. A comparison of medical induction and dilation and evacuation for secondtrimester abortion. Am J Obstet Gynecol 2002;187:393-7. (Pubitemid 34925575)
7. Turok DK, Gurtcheff SE, Esplin MS, Shah M, Simonsen SE, Trauscht-Van Horn J, et al. Second trimester termination of pregnancy: a review by site and procedure type. Contraception 2008;77:155-61.
8. Yapar EG, Senoz S, Urkutur M, Batioglu S, Gokmen O. Second trimester pregnancy termination including fetal death: comparison of five different methods. Eur J Obstet Gynecol Reprod Biol 1996;69:97-102. (Pubitemid 26338313)
9. Bygdeman M, Gemzell-Danielsson K. An historical overview of second trimester abortion methods. Reprod Health Matters 2008;16(31 suppl):196-204.
10. Borgatta L, Chen AY, Vragovic O, Stubblefield PG, Magloire CA. A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion. Contraception 2005;72:358-61. (Pubitemid 41503133)
11. Nuovo J, Melnikow J, Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 2002;287:2813-4. (Pubitemid 34591971)
12. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005;162: 199-200. (Pubitemid 41373523)
13. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370:1453-7.
14. Eskild A, Nesheim BI, Berglund T, Totlandsdal JK, Andresen JF. Induced abortion because of fetal abnormality in Norway, 1996-7[in Norwegian]. Tidsskr Nor Laegeforen 2000;120: 1000-3.
15. Lo TK, Lau WL, Lai FK, Lam HS, Tse HY, Leung WC, et al. Effect of fetal diagnosis on the outcomes of second-trimester pregnancy termination for fetal abnormalities: a pilot study. J Matern Fetal Neonatal Med 2008;21:523-7.
16. Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters 2008;16(31 suppl):162-72.
17. Grimes DA. The choice of second trimester abortion method: evolution, evidence and ethics. Reprod Health Matters 2008; 16(31 suppl):183-8.
18. Owen J, Hauth JC, Winkler CL, Gray SE. Midtrimester pregnancy termination: a randomized trial of prostaglandin E2 versus concentrated oxytocin. Am J Obstet Gynecol 1992; 167(4 pt 1):1112-6.
19. Peterson WF, Berry FN, Grace MR, Gulbranson CL. Secondtrimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol 1983;62:185-90. (Pubitemid 13028976)
20. Jacot FR, Poulin C, Bilodeau AP, Morin M, Moreau S, Gendron F, et al. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. Am J Obstet Gynecol 1993;168: 633-7. (Pubitemid 23069128)
21. Grimes DA, Schulz KF, Cates W Jr, Tyler CW Jr. Midtrimester abortion by dilatation and evacuation: a safe and practical alternative. N Engl J Med 1977;296:1141-5. (Pubitemid 8098387)
22. Grimes DA, Hulka JF, McCutchen ME. Midtrimester abortion by dilatation and evacuation versus intra-amniotic instillation of prostaglandin F2 alpha: a randomized clinical trial. Am J Obstet Gynecol 1980;137:785-90. (Pubitemid 10046454)
23. Grimes DA, Smith MS, Witham AD. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG 2004;111: 148-53. (Pubitemid 38186804)
24. Maternal decision making, ethics, and the law. Committee Opinion No. 321. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;106(5 pt 1):1127-37.
25. Kersting A, Kroker K, Steinhard J, Ludorff K, Wesselmann U, Ohrmann P, et al. Complicated grief after traumatic loss: a 14-month follow up study. Eur Arch Psychiatry Clin Neurosci 2007;257:437-43. (Pubitemid 351208367)
26. Kersting A, Kroker K, Steinhard J, Hoernig-Franz I, Wesselmann U, Luedorff K, et al. Psychological impact on women after second and third trimester termination of pregnancy due to fetal anomalies versus women after preterm birth-a 14-month follow up study. Arch Womens Ment Health 2009; 12:193-201.
27. Korenromp MJ, Christiaens GC, van den Bout J, Mulder EJ, Hunfeld JA, Bilardo CM, et al. Long-term psychological consequences of pregnancy termination for fetal abnormality: a cross-sectional study. Prenat Diagn 2005;25:253-60. (Pubitemid 40478014)